Innate Pharma SA Noncurrent Provisions
Innate Pharma SA (IPHYF) had Noncurrent Provisions of EUR 332.00 thousand as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:NoncurrentProvisions · last filed 2026-04-01
- 2025-12-31: Noncurrent Provisions 332.00K EUR.
- 2025-06-30: Noncurrent Provisions 460.00K EUR.
- 2024-12-31: Noncurrent Provisions 274.00K EUR.
- 2024-06-30: Noncurrent Provisions 294.00K EUR.
| Period end | Noncurrent Provisions |
|---|---|
| 2025-12-31 | 332.00K EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 460.00K EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 274.00K EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 294.00K EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 603.00K EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 494.00K EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 198.00K EUR 20-F · filed 2025-04-30 |
| 2022-06-30 | 253.00K EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 253.00K EUR 20-F · filed 2024-04-04 |
| 2021-06-30 | 226.00K EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 221.00K EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 142.00K EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 38.00K EUR 20-F · filed 2021-04-27 |
| 2017-12-31 | 1.01M EUR 20-F · filed 2020-04-24 |